Foghorn Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Foghorn Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q3 2024.
  • Foghorn Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $24.1M, a 23.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $24.1M -$7.28M -23.2% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $25.5M -$6.1M -19.3% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $28.5M -$4.35M -13.2% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $30M -$4.13M -12.1% Dec 31, 2023 10-Q 2024-11-04
Q3 2023 $31.4M -$4.81M -13.3% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $31.6M -$4.67M -12.9% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $32.9M -$4.52M -12.1% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $34.1M -$4.43M -11.5% Dec 31, 2022 10-K 2024-03-07
Q3 2022 $36.2M -$3.45M -8.71% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $36.3M -$4.41M -10.8% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $37.4M -$4.34M -10.4% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $38.5M -$4.29M -10% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $39.6M -$4.3M -9.79% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $40.7M Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $41.7M Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $42.8M +$41.8M +4056% Dec 31, 2020 10-K/A 2022-08-09
Q3 2020 $43.9M Sep 30, 2020 10-Q 2020-12-04
Q4 2019 $1.03M Dec 31, 2019 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.